)
Tracking COVID-19 vaccine: China's phase 3 vaccine proceedings going smooth
Around 50,000 people, across several countries, are participating in phase 3 clinical trials of a COVID vaccine developed by the China National Biotec Group
Around 50,000 people, across several countries, are participating in phase 3 clinical trials of a COVID vaccine developed by the China National Biotec Group
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)